abstract |
The present invention relates to a use of at least one of ferritin-H and a derivative thereof, of a vector encoding ferritin-H or a derivative thereof, or of a substance changing expression of an endogenous ferritin gene of a cell in the manufacture of a pharmaceutical for suppressing a disease caused or enhanced by the effects of intracellular iron mismanagement. |